B. Galobardes, M. Shaw, D. Lawlor, J. Lynch, and G. Smith. Journal of epidemiology and community health, 60 (2):
95-101(February 2006)4308<m:linebreak></m:linebreak>LR: 20071115; PUBM: Print; JID: 7909766; ppublish;<m:linebreak></m:linebreak>Farmacoeconomia.
H. Gardarsdottir, E. Heerdink, and A. Egberts. Pharmacoepidemiology and drug safety, 15 (5):
338-43(May 2006)4368<br/>PUBM: Print; JID: 9208369; 0 (Antidepressive Agents); ppublish;<br/>Mesures de freqüència.
S. Fieuws, and G. Verbeke. Statistics in medicine, 23 (20):
3093-104(October 2004)4302<m:linebreak></m:linebreak>PUBM: Print; CI: Copyright 2004; JID: 8215016; ppublish;<m:linebreak></m:linebreak>Mixed models.
H. Janes, L. Sheppard, and K. Shepherd. Annals of epidemiology, 18 (10):
792-802(October 2008)4973<m:linebreak></m:linebreak>JID: 9100013; 0 (Air Pollutants); 2008/01/09 received; 2008/05/17 revised; 2008/06/18 accepted; ppublish;.
C. Hewitt, N. Mitchell, and D. Torgerson. BMJ (Clinical research ed.), 336 (7634):
23-5(January 2008)4863<m:linebreak></m:linebreak>LR: 20081120; JID: 8900488; 0 (Abortifacient Agents, Nonsteroidal); 0 (Anesthetics, Local); 137-58-6 (Lidocaine); 59122-46-2 (Misoprostol); OID: NLM: PMC2174757; ppublish; Exemples de recomanacions en sentit contrari als resultats<m:linebreak></m:linebreak>Presentació de dades; Interpretació de resultats.
J. Calvo-Gómez, R. Sánchez-Pedraza, L. Jaramillo-González, and C. Tarcisio-Mantilla. Revista de salud pública (Bogotá, Colombia), 8 (1):
74-87(2006)5444<m:linebreak></m:linebreak>LR: 20061115; JID: 100936348; 0 (Antipsychotic Agents); ppublish;<m:linebreak></m:linebreak>Validació d'escales.
K. Flegal, B. Graubard, and D. Williamson. American journal of epidemiology, 160 (4):
331-8(August 2004)4391<m:linebreak></m:linebreak>LR: 20041117; PUBM: Print; JID: 7910653; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.